The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
Publication date: Available online 19 April 2020Source: Journal of Bone OncologyAuthor(s): Liang Xu, Zhengkao Sun, Xianfu Wei, Hongdong Tan, Peng Kong, Zhenfeng Li, Qiang Yang, E'nuo Dai, Jianmin Li
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
More News: Bone Cancers | Cancer & Oncology | Gastroschisis Repair | Osteosarcoma | Stem Cell Therapy | Stem Cells